A86 CANNABIS USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IS HIGHER FOLLOWING LEGALIZATION OF CANNABIS IN CANADA AND IS ASSOCIATED WITH LOWER QUALITY OF LIFE

BACKGROUND: Patients with inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), often experience fluctuating and unpredictable symptoms. Most individuals require chronic therapy with immunomodulators or novel biologics to maintain disease remission. In additio...

Descripción completa

Detalles Bibliográficos
Autores principales: Iablokov, V, Chande, N, Ponich, T, Jairath, V, Gregor, J, Khanna, R, Asfaha, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Poster Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991158/
http://dx.doi.org/10.1093/jcag/gwac036.086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991158/
http://dx.doi.org/10.1093/jcag/gwac036.086

Ejemplares similares